Drug Approval | August 20, 2024
Granules India receives ANDA approval for Glycopyrrolate Oral Solution
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
_256_384.jpg)
This facility manufactures APIs & formulations of oncology and non-oncology products.
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The facility is over 79,000 square feet and is equipped with packaging lines
Subscribe To Our Newsletter & Stay Updated
